Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Mucositis × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Head & Neck 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Prostatic Neoplasms 4 Multiple Myeloma 4 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Myeloid, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Burkitt Lymphoma 4 Waldenstrom Macroglobulinemia 3 Sezary Syndrome 3 Recurrence 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Mycosis Fungoides 3 Lymphoma, Extranodal NK-T-Cell 3 Leukemia, Hairy Cell 3 Hodgkin Disease 3 Breast Neoplasms 3 Brain Neoplasms 3 Blast Crisis 3 Melanoma 2 Lymphoma, Large-Cell, Anaplastic 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Myeloid, Accelerated Phase 2

Interventions

Cisplatin 4 Radiotherapy 3 Radiation 3 Injections 3 angiotensin I (1-7) 2 Water 2 RRx-001 2 Interleukin 1 Receptor Antagonist Protein 2 Drug Therapy 2 Amifostine 2 tempol 1 peppermint oil 1 pegfilgrastim 1 kang-lai-te 1 hydrated silica gel-based toothpaste 1 fish oil triglycerides 1 brilacidin 1 anise oil 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Xylitol 1 Vaccinium myrtillus extract 1 Tramadol 1 Therapeutics 1 Surgical Procedures, Operative 1 Sorbic Acid 1 Selenomethionine 1 Radiotherapy, Intensity-Modulated 1 Propolis 1 Poloxamer 1 Phosphatidylinositol 3-Kinases 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04046250 2023-08-25

TK112690

Tosk, Inc.

Phase 2 Completed

22 enrolled 10 charts

Head & NeckOther

Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡